possible. What you’ll do As an Associate Market Access Manager, you’ll play a pivotal role in channeling our scientific capabilities..., with compelling and customised value propositions, including economic and clinical arguments to secure access and funding for drugs...
Overview ClinicalResearchAssociate Working Model: Hong Kong Client Office based As a ClinicalResearchAssociate... you will be joining the world’s largest & most comprehensive clinicalresearch organisation, powered by healthcare intelligence...
Fellow, ResearchAssociate, or Research Assistant for conducting translational research on stem cell-based or biomaterial..., translating stem cell-based products for clinical trials or drafting research proposals will be an advantage. Other applicants...
Summary We are seeking a ClinicalResearchAssociate to monitors patient data & study-related information related... (where applicable) Essential Requirements At least 1-2 years ClinicalResearchAssociate working experience or equivalence...
the benefits of our products Effectively communicate the scientific and clinical benefits of our products to top research... to be challenged and empowered to do the things they never thought possible. What You’ll Do As a Senior Key Account Associate/Key...
benefits of our products Effectively communicate the scientific and clinical benefits of our products to top research... to be challenged and empowered to do the things they never thought possible. What you’ll do As a Senior Key Account Associate/Key...
of our products Effectively communicate the scientific and clinical benefits of our products to top research and clinical...Key Account Associate/ Senior Key Account Associate/ Key Account Executive (RI Private and GI Team...
the benefits of our products Effectively communicate the scientific and clinical benefits of our products to top research... Associate/ Senior Key Account Associate/ Key Account Executive, you will promote AstraZeneca’s GU Cancer Stage Portfolio...
Effectively communicate the scientific and clinical benefits of our products to top research and clinical practitioners Build...Key Account Associate/ Senior Key Account Associate/ Key Account Executive (RI Private and GI Team...
on , , , and . Job Description This position is responsible for: Current and upcoming Medical Aesthetics portfolios and their associate indications. Medical..., organizing advisory board meetings, facilitating clinical trials, and serving as the medical resource for both external...
An emotional Elina Svitolina says it is a "difficult day for Ukraine" after Russian strikes on the country killed 31 people and damaged a children's hospital. Continue Reading »
The Ceigall India IPO plans to raise ₹617.69 crore from a fresh issue. The company is going to issue a total of 1.428 crore equity shares for a face value of ₹5 per share. The company filed its draft prospectus with SEBI on March 3, 2024. Continue Reading »
Motilal Oswal report highlighted that the Nifty Microcap 250 and Nifty Smallcap 250 indexes were the top performers, achieving remarkable monthly growth of 11.56% and 7.90%, respectively. Continue Reading »
By 12:30 GMT, Brent crude futures had fallen 42 cents, or 0.5%, to $86.12 a barrel. U.S. West Texas Intermediate (WTI) crude dropped 52 cents, or 0.63%, to $82.64 a barrel. Continue Reading »
According to the draft papers, the IPO comprises a fresh issue of equity shares worth ₹500 crore and an offer for sale (OFS) of up to ₹1,700 crore by promoters and investor shareholders. Continue Reading »
Wall Street: At 9:48 a.m. ET, the Dow Jones was up 0.70 per cent, the S&P 500 was higher 0.24 per cent, the Nasdaq added 0.12 per cent Continue Reading »
Chandan Taparia has recommended three stocks to buy tomorrow, July 9. According to him, these stocks – BHEL, Chambal Fertilizers, GAIL– are technically placed to see a decent upmove. Continue Reading »
The National Stock Exchange last week imposed a price control cap of 90% over the issue price for SME IPOs. The rule means that the listing-day gain can't be more than 90% of the issue price. Some industry experts believe it will discourage speculation, while others worry it could hurt valuations. Continue Reading »
In an exchange filing, the company announced that its board has approved an interim dividend of ₹2.75 per share with a face value of ₹1 each for the financial year 2024-25. Continue Reading »